Drug Trial Radar · NCT00020566
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma
Last checked: Nov 19, 2026Latest source record: Jun 24, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
1,200
Planned (sponsor's estimate)
Start
Feb 2001
Primary completion
Dec 2011
Sponsor
- Lead sponsor
- University of LeicesterAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Cancer Institute (NCI); Children's Cancer and Leukaemia Group; Societe Francaise Oncologie Pediatrique; European Organisation for Research and Treatment of Cancer - EORTC; German Society for Pediatric Oncology and Hematology GPOH gGmbH; Gesellschaft fur Padiatrische Onkologie und Hamatologie - Austria; Swiss Cancer Institute; EBMT Solid Tumors Working Party; Children's Oncology Group
- First posted
- Jan 27, 2003
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Primary purpose
- Treatment
- Who can join
- All sexes, up to 49 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy and kill more tumor cells. It is not yet known if combination chemotherapy is more effective with or without radiation therapy and/or surgery in treating Ewing's sarcoma. PURPOSE: This randomized phase III trial is studying different combination chemotherapy regimens to see how well they work when given with or without peripheral stem cell transplantation, radiation therapy, and/or surgery in treating patients with Ewing's sarcoma.
Conditions
- Sarcoma
Interventions
dactinomycinBiological
Given IV
busulfanDrug
Given orally and IV
doxorubicin hydrochlorideDrug
Given IV
etoposideDrug
Given IV
ifosfamideDrug
Given IV
melphalanDrug
Given orally and IV
vincristine sulfateDrug
Given IV
autologous hematopoietic stem cell transplantationProcedure
Given IV
conventional surgeryProcedure
Given to patients deemed to require it
radiation therapyRadiation
Given to patients deemed to require it
Primary outcomes
What the sponsor says the trial is designed to measure.
- Event-free survival
- Overall survival
Locations
103 sites in 5 countries. Site status is shown where the registry gives one.
UAB Comprehensive Cancer Center
Birmingham, Alabama · Recruiting
Phoenix Children's Hospital
Phoenix, Arizona · Recruiting
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Little Rock, Arkansas · Recruiting
City of Hope Comprehensive Cancer Center
Duarte, California · Recruiting
Childrens Hospital Los Angeles
Los Angeles, California · Recruiting
Southern California Permanente Medical Group
Los Angeles, California · Recruiting
Lucile Packard Children's Hospital at Stanford University Medical Center
Palo Alto, California · Recruiting
Kaiser Permanente Medical Center - Oakland
Sacramento, California · Recruiting
Rady Children's Hospital - San Diego
San Diego, California · Recruiting
UCSF Helen Diller Family Comprehensive Cancer Center
San Francisco, California · Recruiting
Children's Hospital Colorado Center for Cancer and Blood Disorders
Aurora, Colorado · Recruiting
Alfred I. duPont Hospital for Children
Wilmington, Delaware · Recruiting
Children's National Medical Center
Washington D.C., District of Columbia · Recruiting
Nemours Children's Clinic
Jacksonville, Florida · Recruiting
University of Miami Sylvester Comprehensive Cancer Center - Miami
Miami, Florida · Recruiting
Nemours Children's Clinic - Orlando
Orlando, Florida · Recruiting
Nemours Children's Clinic - Pensacola
Pensacola, Florida · Recruiting
All Children's Hospital
St. Petersburg, Florida · Recruiting
St. Joseph's Cancer Institute at St. Joseph's Hospital
Tampa, Florida · Recruiting
Kaplan Cancer Center at St. Mary's Medical Center
West Palm Beach, Florida · Recruiting
AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Egleston Campus
Atlanta, Georgia · Recruiting
Cancer Research Center of Hawaii
Honolulu, Hawaii · Recruiting
Mountain States Tumor Institute at St. Luke's Regional Medical Center
Boise, Idaho · Recruiting
University of Chicago Cancer Research Center
Chicago, Illinois · Recruiting
Saint Jude Midwest Affiliate
Peoria, Illinois · Recruiting
Simmons Cooper Cancer Institute
Springfield, Illinois · Recruiting
Holden Comprehensive Cancer Center at University of Iowa
Iowa City, Iowa · Recruiting
Kosair Children's Hospital
Louisville, Kentucky · Recruiting
Children's Hospital of New Orleans
New Orleans, Louisiana · Recruiting
Alvin and Lois Lapidus Cancer Institute at Sinai Hospital
Baltimore, Maryland · Recruiting
Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute
Boston, Massachusetts · Recruiting
Hurley Medical Center
Flint, Michigan · Recruiting
Helen DeVos Children's Hospital at Spectrum Health
Grand Rapids, Michigan · Recruiting
Van Elslander Cancer Center at St. John Hospital and Medical Center
Grosse Pointe Woods, Michigan · Recruiting
Bronson Methodist Hospital
Kalamazoo, Michigan · Recruiting
Breslin Cancer Center at Ingham Regional Medical Center
Lansing, Michigan · Recruiting
CCOP - Duluth
Duluth, Minnesota · Recruiting
Children's Hospitals and Clinics of Minnesota - Minneapolis
Minneapolis, Minnesota · Recruiting
Masonic Cancer Center at University of Minnesota
Minneapolis, Minnesota · Recruiting
Mayo Clinic Cancer Center
Rochester, Minnesota · Recruiting
Showing 40 of 103 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.